Siglec-7 is a predictive biomarker for the efficacy of cancer vaccination against metastatic colorectal cancer

Cancer immunotherapy, including vaccination, is considered a major scientific and medical breakthrough. However, cancer immunotherapy does not result in durable objective responses against colorectal cancer (CRC). To improve the efficacy of immunotherapy, the present study investigated several bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Kensuke, Hazama, Shoichi, Suzuki, Nobuaki, Xu, Ming, Nakagami, Yuki, Fujiwara, Nobuyuki, Tsunedomi, Ryouichi, Yoshida, Shin, Tomochika, Shinobu, Matsukuma, Satoshi, Matsui, Hiroto, Tokumitsu, Yukio, Kanekiyo, Shinsuke, Shindo, Yoshitaro, Watanabe, Yusaku, Iida, Michihisa, Takeda, Shigeru, Ioka, Tatsuya, Ueno, Tomio, Ogihara, Hiroyuki, Hamamoto, Yoshihiko, Hoshii, Yoshinobu, Kawano, Hiroo, Fujita, Tomonobu, Kawakami, Yutaka, Nagano, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681234/
https://www.ncbi.nlm.nih.gov/pubmed/33240416
http://dx.doi.org/10.3892/ol.2020.12271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681234/
https://www.ncbi.nlm.nih.gov/pubmed/33240416
http://dx.doi.org/10.3892/ol.2020.12271

Ejemplares similares